PTGX logo

Protagonist Therapeutics (PTGX) CAPEX

annual CAPEX:

$1.35M+$746.00K(+122.50%)
December 31, 2024

Summary

  • As of today (July 1, 2025), PTGX annual capital expenditures is $1.35 million, with the most recent change of +$746.00 thousand (+122.50%) on December 31, 2024.
  • During the last 3 years, PTGX annual CAPEX has risen by +$254.00 thousand (+23.07%).
  • PTGX annual CAPEX is now at all-time high.

Performance

PTGX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXcash flow metrics

quarterly CAPEX:

$545.00K+$235.00K(+75.81%)
March 1, 2025

Summary

  • As of today (July 1, 2025), PTGX quarterly capital expenditures is $545.00 thousand, with the most recent change of +$235.00 thousand (+75.81%) on March 1, 2025.
  • Over the past year, PTGX quarterly CAPEX has increased by +$303.00 thousand (+125.21%).
  • PTGX quarterly CAPEX is now -38.90% below its all-time high of $892.00 thousand, reached on June 30, 2019.

Performance

PTGX quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXcash flow metrics

TTM CAPEX:

$1.66M+$303.00K(+22.36%)
March 1, 2025

Summary

  • As of today (July 1, 2025), PTGX TTM capital expenditures is $1.66 million, with the most recent change of +$303.00 thousand (+22.36%) on March 1, 2025.
  • Over the past year, PTGX TTM CAPEX has increased by +$817.00 thousand (+97.15%).
  • PTGX TTM CAPEX is now at all-time high.

Performance

PTGX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXcash flow metrics

PTGX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+122.5%+125.2%+97.2%
3 y3 years+23.1%+99.6%+34.4%
5 y5 years+40.1%+294.9%+821.1%

PTGX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+122.5%-29.7%+5350.0%at high+296.6%
5 y5-yearat high+187.7%-29.7%+5350.0%at high+821.1%
alltimeall timeat high+187.7%-38.9%+276.4%at high+821.1%

PTGX CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$545.00K(+75.8%)
$1.66M(+22.4%)
Dec 2024
$1.35M(+122.5%)
$310.00K(-60.0%)
$1.35M(+27.3%)
Sep 2024
-
$775.00K(+2667.9%)
$1.06M(+53.5%)
Jun 2024
-
$28.00K(-88.4%)
$693.00K(-17.6%)
Mar 2024
-
$242.00K(+1173.7%)
$841.00K(+38.1%)
Dec 2023
$609.00K(-23.4%)
$19.00K(-95.3%)
$609.00K(-7.7%)
Sep 2023
-
$404.00K(+129.5%)
$660.00K(+57.9%)
Jun 2023
-
$176.00K(+1660.0%)
$418.00K(-21.4%)
Mar 2023
-
$10.00K(-85.7%)
$532.00K(-33.1%)
Dec 2022
$795.00K(-27.8%)
$70.00K(-56.8%)
$795.00K(-13.7%)
Sep 2022
-
$162.00K(-44.1%)
$921.00K(-10.1%)
Jun 2022
-
$290.00K(+6.2%)
$1.02M(-17.0%)
Mar 2022
-
$273.00K(+39.3%)
$1.23M(+12.1%)
Dec 2021
$1.10M
$196.00K(-26.0%)
$1.10M(+6.9%)
Sep 2021
-
$265.00K(-47.0%)
$1.03M(+22.6%)
DateAnnualQuarterlyTTM
Jun 2021
-
$500.00K(+257.1%)
$840.00K(+77.6%)
Mar 2021
-
$140.00K(+12.0%)
$473.00K(+0.4%)
Dec 2020
$471.00K(-51.3%)
$125.00K(+66.7%)
$471.00K(-16.5%)
Sep 2020
-
$75.00K(-43.6%)
$564.00K(+213.3%)
Jun 2020
-
$133.00K(-3.6%)
$180.00K(-80.8%)
Mar 2020
-
$138.00K(-36.7%)
$939.00K(-2.9%)
Dec 2019
$967.00K(+99.0%)
$218.00K(-170.6%)
$967.00K(+19.2%)
Sep 2019
-
-$309.00K(-134.6%)
$811.00K(-36.0%)
Jun 2019
-
$892.00K(+437.3%)
$1.27M(+185.6%)
Mar 2019
-
$166.00K(+167.7%)
$444.00K(-8.6%)
Dec 2018
$486.00K(-27.0%)
$62.00K(-58.1%)
$486.00K(+1.3%)
Sep 2018
-
$148.00K(+117.6%)
$480.00K(-8.0%)
Jun 2018
-
$68.00K(-67.3%)
$522.00K(+15.0%)
Mar 2018
-
$208.00K(+271.4%)
$454.00K(+84.6%)
Dec 2017
$666.00K
$56.00K(-70.5%)
$246.00K(+29.5%)
Sep 2017
-
$190.00K
$190.00K

FAQ

  • What is Protagonist Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Protagonist Therapeutics?
  • What is Protagonist Therapeutics annual CAPEX year-on-year change?
  • What is Protagonist Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Protagonist Therapeutics?
  • What is Protagonist Therapeutics quarterly CAPEX year-on-year change?
  • What is Protagonist Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Protagonist Therapeutics?
  • What is Protagonist Therapeutics TTM CAPEX year-on-year change?

What is Protagonist Therapeutics annual capital expenditures?

The current annual CAPEX of PTGX is $1.35M

What is the all time high annual CAPEX for Protagonist Therapeutics?

Protagonist Therapeutics all-time high annual capital expenditures is $1.35M

What is Protagonist Therapeutics annual CAPEX year-on-year change?

Over the past year, PTGX annual capital expenditures has changed by +$746.00K (+122.50%)

What is Protagonist Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of PTGX is $545.00K

What is the all time high quarterly CAPEX for Protagonist Therapeutics?

Protagonist Therapeutics all-time high quarterly capital expenditures is $892.00K

What is Protagonist Therapeutics quarterly CAPEX year-on-year change?

Over the past year, PTGX quarterly capital expenditures has changed by +$303.00K (+125.21%)

What is Protagonist Therapeutics TTM capital expenditures?

The current TTM CAPEX of PTGX is $1.66M

What is the all time high TTM CAPEX for Protagonist Therapeutics?

Protagonist Therapeutics all-time high TTM capital expenditures is $1.66M

What is Protagonist Therapeutics TTM CAPEX year-on-year change?

Over the past year, PTGX TTM capital expenditures has changed by +$817.00K (+97.15%)
On this page